Event
Public Workshop
Generic Drug Repurposing: Exploring the Potential Role of the Regulator and Policy Solutions
Hybrid - Duke in DC Office

This hybrid workshop will provide a forum for participants to discuss the potential role of the regulator as it relates to generic drug repurposing. Discussion will explore a range of proposed solutions that aim to address challenges in identifying drug repurposing targets, seeking label expansion by nontraditional developers, and ensuring responsible drug promotion and public health benefit. The goal of this workshop is to identify priority recommendations and opportunities to address key regulatory challenges and help to unlock the full potential of generic drugs.
Funding for this project was made possible in part by Arnold Ventures LLC. The views expressed in events, written materials, or publications and by participants do not necessarily reflect the official views or endorsement by Arnold Ventures LLC.
Duke-Margolis Planning Team

Beth Boyer, MPH
Policy Research Associate

Gerrit Hamre, MA
Research Director for Biomedical Regulatory Policy

Mia Williams, MPH, CHES
Policy Analyst